SLC40A1 and breast carcinoma: Concomitantly, while breast cancer cells display an “iron-utilization” phenotype characterized by increased expression of hepcidin and Tfr1 and decreased expression of ferritin, macrophages in primary tumors and metastasized lymph nodes manifest an “iron-donor” phenotype characterized by increased expression of ferroportin and ferritin (41).